STOCKWATCH
·
Medical/Dental Instruments
DelistingApr 10, 2026, 04:41 PM

Beyond Air Receives Nasdaq Delisting Notice for Bid Price Rule

AI Summary

Beyond Air, Inc. received a delisting notification from Nasdaq on April 7, 2026, for failing to maintain the minimum $1.00 bid price requirement. The company's common stock traded below $1.00 for 30 consecutive business days from February 23, 2026, to April 6, 2026. Due to a reverse stock split effected within the prior year, Beyond Air is not eligible for the standard 180-calendar day compliance period. The company plans to timely request a hearing before the Nasdaq Hearings Panel by April 14, 2026, which will stay any further delisting action.

Key Highlights

  • Beyond Air received a Nasdaq delisting notice on April 7, 2026.
  • The company failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days.
  • No 180-day compliance period due to a 1-for-20 reverse stock split on July 14, 2025.
  • Beyond Air intends to request a hearing by April 14, 2026, to appeal the decision.
XAIR
Medical/Dental Instruments
Beyond Air, Inc.

Price Impact